| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A major turning point in NK/T-cell lymphoma?
|
Jaccard, Arnaud
|
|
|
129 |
17 |
p. 2342-2343
|
artikel
|
| 2 |
Complex formation with pentraxin-2 regulates factor X plasma levels and macrophage interactions
|
Muczynski, Vincent
|
|
|
129 |
17 |
p. 2443-2454
|
artikel
|
| 3 |
De novo Richter transformation
|
Chiecchio, Laura
|
|
|
129 |
17 |
p. 2455
|
artikel
|
| 4 |
Editorial Board
|
|
|
|
129 |
17 |
p. i
|
artikel
|
| 5 |
Eliglustat maintains long-term clinical stability in patients with Gaucher disease type 1 stabilized on enzyme therapy
|
Cox, Timothy M.
|
|
|
129 |
17 |
p. 2375-2383
|
artikel
|
| 6 |
Encore! Oral therapy for type 1 Gaucher disease
|
Weinreb, Neal J.
|
|
|
129 |
17 |
p. 2337-2338
|
artikel
|
| 7 |
EZH! The IRE of DLBCL gets an UPR hand
|
Katz, Samuel G.
|
|
|
129 |
17 |
p. 2340-2342
|
artikel
|
| 8 |
Genetic abnormalities in myelodysplasia and secondary acute myeloid leukemia: impact on outcome of stem cell transplantation
|
Yoshizato, Tetsuichi
|
|
|
129 |
17 |
p. 2347-2358
|
artikel
|
| 9 |
Genomics trumps clinical criteria in BMT? Nyet!
|
Holtzman, Noa G.
|
|
|
129 |
17 |
p. 2335-2336
|
artikel
|
| 10 |
How I manage the toxicities of myeloma drugs
|
Delforge, Michel
|
|
|
129 |
17 |
p. 2359-2367
|
artikel
|
| 11 |
Impairment of both IRE1 expression and XBP1 activation is a hallmark of GCB DLBCL and contributes to tumor growth
|
Bujisic, Bojan
|
|
|
129 |
17 |
p. 2420-2428
|
artikel
|
| 12 |
miR-28 regulates the germinal center reaction and blocks tumor growth in preclinical models of non-Hodgkin lymphoma
|
Bartolomé-Izquierdo, Nahikari
|
|
|
129 |
17 |
p. 2408-2419
|
artikel
|
| 13 |
Optimized depletion of chimeric antigen receptor T cells in murine xenograft models of human acute myeloid leukemia
|
Tasian, Sarah K.
|
|
|
129 |
17 |
p. 2395-2407
|
artikel
|
| 14 |
PD1 blockade with pembrolizumab is highly effective in relapsed or refractory NK/T-cell lymphoma failing l-asparaginase
|
Kwong, Yok-Lam
|
|
|
129 |
17 |
p. 2437-2442
|
artikel
|
| 15 |
Prognostic role of circulating exosomal miRNAs in multiple myeloma
|
Manier, Salomon
|
|
|
129 |
17 |
p. 2429-2436
|
artikel
|
| 16 |
Prophylaxis usage, bleeding rates, and joint outcomes of hemophilia, 1999 to 2010: a surveillance project
|
Manco-Johnson, Marilyn J.
|
|
|
129 |
17 |
p. 2368-2374
|
artikel
|
| 17 |
Ribosomes in platelets protect the messenger
|
Rowley, Jesse W.
|
|
|
129 |
17 |
p. 2343-2345
|
artikel
|
| 18 |
Single-cell molecular analysis defines therapy response and immunophenotype of stem cell subpopulations in CML
|
Warfvinge, Rebecca
|
|
|
129 |
17 |
p. 2384-2394
|
artikel
|
| 19 |
Slowed decay of mRNAs enhances platelet specific translation
|
Mills, Eric W.
|
|
|
129 |
17 |
p. e38-e48
|
artikel
|
| 20 |
The thin line between CML and CMML
|
Parilla, Megan
|
|
|
129 |
17 |
p. 2456
|
artikel
|
| 21 |
Understanding CML, 1 cell at a time
|
Radich, Jerald
|
|
|
129 |
17 |
p. 2339-2340
|
artikel
|
Tijdschrift beschrijving